Company MiMedx Group Inc OTC Bulletin Board
Equities
Biotechnology & Medical Research
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Hospital
58.2
%
| - | - | 187 | 58.2 % | - |
Private Office
29.8
%
| - | - | 96 | 29.8 % | - |
Other
12.0
%
| - | - | 39 | 12.0 % | - |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 268 | 100.0 % | 321 | 100.0 % | +20.03% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Joe Capper
CEO | Chief Executive Officer | 61 | 26/01/23 |
Douglas Rice
DFI | Director of Finance/CFO | 58 | 04/07/23 |
John R. Harper
CTO | Chief Tech/Sci/R&D Officer | - | 31/05/21 |
Mark P. Graves
CMP | Compliance Officer | 59 | 30/06/18 |
Ricci Whitlow
COO | Chief Operating Officer | 55 | 02/01/23 |
William Hulse
ADM | Chief Administrative Officer | 50 | 01/12/19 |
David H. Mason
CTO | Chief Tech/Sci/R&D Officer | 77 | 18/06/14 |
K. Newton
BRD | Director/Board Member | 61 | 18/06/19 |
Eric Smith
SAM | Sales & Marketing | - | 31/12/20 |
Kim Moller
SAM | Sales & Marketing | - | 31/07/20 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
William Hawkins
BRD | Director/Board Member | 70 | 01/07/20 |
K. Newton
BRD | Director/Board Member | 61 | 18/06/19 |
M. Wilsey
CHM | Chairman | 71 | 18/06/19 |
James Bierman
BRD | Director/Board Member | 71 | 18/06/19 |
Martin Sutter
BRD | Director/Board Member | 69 | 01/07/20 |
Joe Capper
CEO | Chief Executive Officer | 61 | 26/01/23 |
Cato Laurencin
BRD | Director/Board Member | 65 | 31/10/20 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 147,603,955 | 144,174,265 ( 97.68 %) | 0 | 97.68 % |
Company contact information
Sector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
-19.95% | 129M | |
-19.72% | 58.76M | |
+0.95% | 57.74M | |
-4.19% | 50.25M |